Grant: Project Grant
Université Laval
$921,826.00
Adipose-centered therapeutic strategies for menopause-associated metabolic dysfunction
EF 2025-26
Résumé
After menopause, many women experience weight gain around the abdomen, reduced energy expenditure, and worsening control of blood sugar. These changes greatly increase the risk of type 2 diabetes, heart disease, and fatty liver disease. Current treatments, including hormone therapy and diabetes medications, only partly address these problems and may not be suitable or effective for all women. As a result, there is a critical need for new, non-hormonal strategies that directly improve metabolic health after menopause.
This project aims to understand how changes in fat tissue function during menopause contribute to impaired glucose control and metabolic disease, and to identify new ways to restore healthy metabolism. Using mouse models that closely mimic the natural menopausal transition and female aging, we will examine how fat tissue remodeling affects energy balance, blood sugar regulation, and liver health. We aim to will identify when metabolic vulnerability emerges and determine the best windows for therapeutic intervention.
Programme
Project Grant
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
564359
Name
Caron Alexandre
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Gender and Health
Theme2
Biomedical
Prcname2
Gender, Sex & Health
Projecttitle
Adipose-centered therapeutic strategies for menopause-associated metabolic dysfunction
Programtype2
Operating Grants
Orgnameinp2
Université Laval
Cihramount2
$921,826
Cihrequipment2
$0
Programname2
Project Grant
Keyworddelim
Adipose Tissue; Autonomic Remodeling; Female; Glucose Homeostasis; Gonadal Steroid Hormones; Menopause; Metabolic Dysfunction; Mirabegron; Non-Hormonal Therapy; Visceral Adiposity
Abstract
After menopause, many women experience weight gain around the abdomen, reduced energy expenditure, and worsening control of blood sugar. These changes greatly increase the risk of type 2 diabetes, heart disease, and fatty liver disease. Current treatments, including hormone therapy and diabetes medications, only partly address these problems and may not be suitable or effective for all women. As a result, there is a critical need for new, non-hormonal strategies that directly improve metabolic health after menopause.
This project aims to understand how changes in fat tissue function during menopause contribute to impaired glucose control and metabolic disease, and to identify new ways to restore healthy metabolism. Using mouse models that closely mimic the natural menopausal transition and female aging, we will examine how fat tissue remodeling affects energy balance, blood sugar regulation, and liver health. We aim to will identify when metabolic vulnerability emerges and determine the best windows for therapeutic intervention.
Competitiondate
202603
Approvedterm2
5 yrs 0 mth
Pinamesdelim
Caron, Alexandre
Approvedterm
5 ans 0 mois
Cihrcontribution2
~ $921,826~ $0~